What are the major opportunities in the Glioblastoma Multiforme market? What are the strategies for the Glioblastoma Multiforme market?

For detailed insights on the major opportunities and strategies in the Glioblastoma Multiforme market, Read More

How does the Glioblastoma Multiforme market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Glioblastoma Multiforme market growth and SWOT analysis of the Glioblastoma Multiforme industry, Read More

For detailed insights on the mergers and acquisitions in the Glioblastoma Multiforme industry,

What are the key dynamics influencing the Glioblastoma Multiforme market growth? SWOT analysis of the Glioblastoma Multiforme market. Read More

Glioblastoma Multiforme Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Glioblastoma Multiforme Market Report 2026

Name: Glioblastoma Multiforme Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Chemotherapy Agents, Temozolomide, Carmustine, Lomustine, Other Drug Classes), By Diagnostic Tools (Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), Biopsy, Other Diagnostic Tools), By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Tumor Treating Field Therapy, Other Treatment Types), By End-User (Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Glioblastoma Multiforme Market Overview

• Glioblastoma Multiforme market size has reached to $2.7 billion in 2025

• Expected to grow to $3.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Impact Of Rising Brain Disorder Cases On The Market Growth

• Market Trend: Advancements In CAR T-Cell Therapies For Glioblastoma Multiforme Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Glioblastoma Multiforme Market?

Glioblastoma multiforme (GBM) is an aggressive and fast-growing brain tumor that originates in the glial cells of the brain. It is the lethal form of primary brain cancer, characterized by rapid proliferation and resistance to standard treatments.

The main types of drug classes for glioblastoma multiforme are chemotherapy agents, temozolomide, carmustine, lomustine, and others. Chemotherapy agents for glioblastoma multiforme target and disrupt cancer cell division, helping control tumor growth and improve survival, often in combination with other treatments. It is diagnosed by various diagnostic tools such as magnetic resonance imaging (MRI), computed tomography scan (CT scan), biopsy, and others and treated with several treatment types, including surgery, radiation therapy, chemotherapy, immunotherapy, tumor treating field therapy, and others. It is used by various end-users, such as hospitals, cancer research institutes, ambulatory surgical centers, and others.

Glioblastoma Multiforme Market Global Report 2026 Market Report bar graph

What Is The Glioblastoma Multiforme Market Size and Share 2026?

The glioblastoma multiforme market size has grown strongly in recent years. It will grow from $2.7 billion in 2025 to $2.92 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to limited treatment options, advancements in neuro-oncology, chemotherapy standardization, growth of cancer research centers, improved imaging technologies.

What Is The Glioblastoma Multiforme Market Growth Forecast?

The glioblastoma multiforme market size is expected to see strong growth in the next few years. It will grow to $3.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to development of novel targeted drugs, expansion of immunotherapy research, personalized cancer treatment adoption, increased funding for brain cancer research, improved survival outcome focus. Major trends in the forecast period include increased focus on targeted cancer therapies, rising use of multimodal treatment approaches, expansion of precision oncology research, growing adoption of advanced imaging diagnostics, improved clinical trial participation.

Book your 30 minutes free consultation with our research experts

Global Glioblastoma Multiforme Market Segmentation

1) By Drug Class: Chemotherapy Agents, Temozolomide, Carmustine, Lomustine, Other Drug Classes

2) By Diagnostic Tools: Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), Biopsy, Other Diagnostic Tools

3) By Treatment Type: Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Tumor Treating Field Therapy, Other Treatment Types

4) By End-User: Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Chemotherapy Agents: Alkylating Agents, Platinum-Based Agents, Antimetabolites

2) By Temozolomide: Branded (Temodar), Generic Temozolomide

3) By Carmustine: Injectable Carmustine, Carmustine Wafers (Gliadel)

4) By Lomustine: Branded (Gleostine), Generic Lomustine

5) By Other Drug Classes: Targeted Therapy, Immunotherapy, Tumor-Treating Fields (TTF) Therapy

What Is The Driver Of The Glioblastoma Multiforme Market?

The rising brain disorder cases are expected to drive the glioblastoma multiforme market going forward. A brain disorder is a condition that affects the structure or function of the brain, leading to cognitive, emotional, or physical impairments. Rising brain disorder cases are due to factors such as aging populations, increased life expectancy, lifestyle factors, and improved diagnostic capabilities. Understanding brain disorders helps advance research on glioblastoma multiforme (GBM), leading to better early detection, innovative treatments, and improved patient outcomes. By studying neurological conditions, scientists can uncover genetic and molecular links that contribute to GBM development. For instance, in February 2025, according to Dementia Australia, an Australia-based non-profit organization, approximately 433,300 Australians are living with dementia, with this number expected to rise to 812,500 by 2054. Additionally, younger-onset dementia affects around 29,000 people in 2025, with projections indicating an increase to 41,000 by 2054. Therefore, the rising brain disorder cases will drive the growth of the glioblastoma multiforme industry.

Key Players In The Global Glioblastoma Multiforme Market

Major companies operating in the glioblastoma multiforme market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Accord Healthcare Inc., Sumitomo Dainippon Pharma Oncology Inc., Karyopharm Therapeutics Inc., ITM Isotope Technologies Munich SE, Azurity Pharmaceuticals Inc., Genenta Science S.p.A., Chimeric Therapeutics Limited, VBI Vaccines Inc.

Global Glioblastoma Multiforme Market Trends and Insights

Major companies operating in the glioblastoma multiforme market are focusing on developing advanced therapies, such as CAR T-cell therapies, to address the unmet medical needs of aggressive cancer. CAR T-cell therapies are a form of immunotherapy that involves modifying a patient's T-cells to target and kill cancer cells more effectively. For instance, in June 2023, Chimeric Therapeutics Limited, an Australia-based biotech company, launched a Phase IB clinical trial of CHM 1101 (CLXT CAR T) therapy for recurrent or progressive glioblastoma multiforme (GBM). The trial, conducted at multiple centers, aims to evaluate the therapy's safety and efficacy while determining the recommended Phase 2 dose. Initial Phase 1a results showed disease stability, and the trial will build on this to support further development. The company plans to use the data to design a registration trial and seek regulatory feedback.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Glioblastoma Multiforme Market?

In October 2024, Merck & Co., a US-based pharmaceutical company specializing in prescription medicines and vaccines, acquired Modifi Biosciences for an undisclosed amount. Through this acquisition, Merck aims to advance its oncology pipeline by integrating Modifi’s preclinical small-molecule platform, which targets cancer cells with defects in deoxyribonucleic acid (DNA) repair, including those lacking the O6-methylguanine-DNA methyltransferase (MGMT) protein, and shows potential against highly refractory tumors such as glioblastoma. Modifi Biosciences Inc. is a US-based company that provides a treatment targeting Glioblastoma Multiforme (GBM).

Regional Outlook

North America was the largest region in the glioblastoma multiforme market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Glioblastoma Multiforme Market?

The glioblastoma multiforme market consists of revenues earned by entities by providing services such as palliative care, psychosocial support, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The glioblastoma multiforme market also includes sales of drugs, diagnostic tools, personalized medicine, and advanced drug delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Glioblastoma Multiforme Market Report 2026?

The glioblastoma multiforme market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the glioblastoma multiforme industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Glioblastoma Multiforme Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.92 billion
Revenue Forecast In 2035	$3.94 billion
Growth Rate	CAGR of 8.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Diagnostic Tools, Treatment Type, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Accord Healthcare Inc., Sumitomo Dainippon Pharma Oncology Inc., Karyopharm Therapeutics Inc., ITM Isotope Technologies Munich SE, Azurity Pharmaceuticals Inc., Genenta Science S.p.A., Chimeric Therapeutics Limited, VBI Vaccines Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Glioblastoma Multiforme Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Glioblastoma Multiforme Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Glioblastoma Multiforme Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Glioblastoma Multiforme Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Industry 4.0 And Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increased Focus On Targeted Cancer Therapies

4.2.2 Rising Use Of Multimodal Treatment Approaches

4.2.3 Expansion Of Precision Oncology Research

4.2.4 Growing Adoption Of Advanced Imaging Diagnostics

4.2.5 Improved Clinical Trial Participation

5. Glioblastoma Multiforme Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Treatment Centers

5.3 Neurosurgery Clinics

5.4 Oncology Research Institutes

5.5 Ambulatory Surgical Centers

6. Glioblastoma Multiforme Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Glioblastoma Multiforme Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Glioblastoma Multiforme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Glioblastoma Multiforme Market Size, Comparisons And Growth Rate Analysis

7.3. Global Glioblastoma Multiforme Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Glioblastoma Multiforme Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Glioblastoma Multiforme Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Glioblastoma Multiforme Market Segmentation

9.1. Global Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy Agents, Temozolomide, Carmustine, Lomustine, Other Drug Classes

9.2. Global Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), Biopsy, Other Diagnostic Tools

9.3. Global Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Tumor Treating Field Therapy, Other Treatment Types

9.4. Global Glioblastoma Multiforme Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Cancer Research Institutes, Ambulatory Surgical Centers, Other End-Users

9.5. Global Glioblastoma Multiforme Market, Sub-Segmentation Of Chemotherapy Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alkylating Agents, Platinum-Based Agents, Antimetabolites

9.6. Global Glioblastoma Multiforme Market, Sub-Segmentation Of Temozolomide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Branded (Temodar), Generic Temozolomide

9.7. Global Glioblastoma Multiforme Market, Sub-Segmentation Of Carmustine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable Carmustine, Carmustine Wafers (Gliadel)

9.8. Global Glioblastoma Multiforme Market, Sub-Segmentation Of Lomustine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Branded (Gleostine), Generic Lomustine

9.9. Global Glioblastoma Multiforme Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Therapy, Immunotherapy, Tumor-Treating Fields (TTF) Therapy

10. Glioblastoma Multiforme Market Regional And Country Analysis

10.1. Global Glioblastoma Multiforme Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Glioblastoma Multiforme Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Glioblastoma Multiforme Market

11.1. Asia-Pacific Glioblastoma Multiforme Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Glioblastoma Multiforme Market

12.1. China Glioblastoma Multiforme Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Glioblastoma Multiforme Market

13.1. India Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Glioblastoma Multiforme Market

14.1. Japan Glioblastoma Multiforme Market Overview

14.2. Japan Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Glioblastoma Multiforme Market

15.1. Australia Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Glioblastoma Multiforme Market

16.1. Indonesia Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Glioblastoma Multiforme Market

17.1. South Korea Glioblastoma Multiforme Market Overview

17.2. South Korea Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Glioblastoma Multiforme Market

18.1. Taiwan Glioblastoma Multiforme Market Overview

18.2. Taiwan Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Glioblastoma Multiforme Market

19.1. South East Asia Glioblastoma Multiforme Market Overview

19.2. South East Asia Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Glioblastoma Multiforme Market

20.1. Western Europe Glioblastoma Multiforme Market Overview

20.2. Western Europe Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Glioblastoma Multiforme Market

21.1. UK Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Glioblastoma Multiforme Market

22.1. Germany Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Glioblastoma Multiforme Market

23.1. France Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Glioblastoma Multiforme Market

24.1. Italy Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Glioblastoma Multiforme Market

25.1. Spain Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Glioblastoma Multiforme Market

26.1. Eastern Europe Glioblastoma Multiforme Market Overview

26.2. Eastern Europe Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Glioblastoma Multiforme Market

27.1. Russia Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Glioblastoma Multiforme Market

28.1. North America Glioblastoma Multiforme Market Overview

28.2. North America Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Glioblastoma Multiforme Market

29.1. USA Glioblastoma Multiforme Market Overview

29.2. USA Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Glioblastoma Multiforme Market

30.1. Canada Glioblastoma Multiforme Market Overview

30.2. Canada Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Glioblastoma Multiforme Market

31.1. South America Glioblastoma Multiforme Market Overview

31.2. South America Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Glioblastoma Multiforme Market

32.1. Brazil Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Glioblastoma Multiforme Market

33.1. Middle East Glioblastoma Multiforme Market Overview

33.2. Middle East Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Glioblastoma Multiforme Market

34.1. Africa Glioblastoma Multiforme Market Overview

34.2. Africa Glioblastoma Multiforme Market, Segmentation By Drug Class, Segmentation By Diagnostic Tools, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Glioblastoma Multiforme Market Regulatory and Investment Landscape

36. Glioblastoma Multiforme Market Competitive Landscape And Company Profiles

36.1. Glioblastoma Multiforme Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Glioblastoma Multiforme Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Glioblastoma Multiforme Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

37. Glioblastoma Multiforme Market Other Major And Innovative Companies

Novartis International AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Accord Healthcare Inc., Sumitomo Dainippon Pharma Oncology Inc., Karyopharm Therapeutics Inc., ITM Isotope Technologies Munich SE, Azurity Pharmaceuticals Inc., Genenta Science S.p.A., Chimeric Therapeutics Limited, VBI Vaccines Inc.

38. Global Glioblastoma Multiforme Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Glioblastoma Multiforme Market

40. Glioblastoma Multiforme Market High Potential Countries, Segments and Strategies

40.1 Glioblastoma Multiforme Market In 2030 - Countries Offering Most New Opportunities

40.2 Glioblastoma Multiforme Market In 2030 - Segments Offering Most New Opportunities

40.3 Glioblastoma Multiforme Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Glioblastoma Multiforme Market, Overview Of Key Products - Product Examples

Table 2: Global Glioblastoma Multiforme Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Glioblastoma Multiforme Market, Supply Chain Analysis

Table 4: Global Glioblastoma Multiforme Market, Major Raw Material Providers

Table 5: Global Glioblastoma Multiforme Market, Major Resource Providers

Table 6: Global Glioblastoma Multiforme Market, Major Manufacturers (Suppliers)

Table 7: Global Glioblastoma Multiforme Market, Major Distributors And Channel Partners

Table 8: Global Glioblastoma Multiforme Market, Key Technologies & Future Trends

Table 9: Global Glioblastoma Multiforme Market, Major Trends

Table 10: Global Glioblastoma Multiforme Market, Major End Users

Table 11: Global Glioblastoma Multiforme Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Glioblastoma Multiforme Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Glioblastoma Multiforme Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Glioblastoma Multiforme Market - TAM, US$ Billion, 2025

Table 15: Global Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Glioblastoma Multiforme Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Chemotherapy Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Temozolomide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Carmustine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Lomustine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Glioblastoma Multiforme Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Glioblastoma Multiforme Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Glioblastoma Multiforme Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Glioblastoma Multiforme Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: F. Hoffmann-La Roche Ltd. Financial Performance

Table 102: AbbVie Inc. Financial Performance

Table 103: Bristol Myers Squibb Company Financial Performance

Table 104: AstraZeneca PLC Financial Performance

Table 105: Global Glioblastoma Multiforme Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Glioblastoma Multiforme Market, Competitive Dashboard

Table 107: Global Glioblastoma Multiforme Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Glioblastoma Multiforme Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 109: Global, Glioblastoma Multiforme Market Size Gain ($ Billion), Segmentation By Diagnostic Tools, 2025 – 2030

Table 110: Global, Glioblastoma Multiforme Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

List Of Figures

Figure 1: Global Glioblastoma Multiforme Market, Overview Of Key Products - Product Examples

Figure 2: Global Glioblastoma Multiforme Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Glioblastoma Multiforme Market, Supply Chain Analysis

Figure 4: Global Glioblastoma Multiforme Market, Major Raw Material Providers

Figure 5: Global Glioblastoma Multiforme Market, Major Resource Providers

Figure 6: Global Glioblastoma Multiforme Market, Major Manufacturers (Suppliers)

Figure 7: Global Glioblastoma Multiforme Market, Major Distributors And Channel Partners

Figure 8: Global Glioblastoma Multiforme Market, Key Technologies & Future Trends

Figure 9: Global Glioblastoma Multiforme Market, Major Trends

Figure 10: Global Glioblastoma Multiforme Market, Major End Users

Figure 11: Global Glioblastoma Multiforme Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Glioblastoma Multiforme Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Glioblastoma Multiforme Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Glioblastoma Multiforme Market - TAM, US$ Billion, 2025

Figure 15: Global Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Glioblastoma Multiforme Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Chemotherapy Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Temozolomide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Carmustine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Lomustine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Glioblastoma Multiforme Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Glioblastoma Multiforme Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Glioblastoma Multiforme Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Glioblastoma Multiforme Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Glioblastoma Multiforme Market, Segmentation By Diagnostic Tools, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Glioblastoma Multiforme Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Glioblastoma Multiforme Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Glioblastoma Multiforme Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 102: AbbVie Inc. Financial Performance

Figure 103: Bristol Myers Squibb Company Financial Performance

Figure 104: AstraZeneca PLC Financial Performance

Figure 105: Global Glioblastoma Multiforme Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Glioblastoma Multiforme Market, Competitive Dashboard

Figure 107: Global Glioblastoma Multiforme Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Glioblastoma Multiforme Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 109: Global, Glioblastoma Multiforme Market Size Gain ($ Billion), Segmentation By Diagnostic Tools, 2025 – 2030

Figure 110: Global, Glioblastoma Multiforme Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Glioblastoma Multiforme (GBM) Treatment Market Report 2026 - Global Outlook – By Treatment (Surgery, Radiation Therapy, Chemotherapy, R Immunotherapy), By Drug Class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafe...

Glioma Treatment Market Report 2026 - Global Outlook – By Type (Low-Grade, High-Grade), By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases), By Route Of Administrati...

Adult Malignant Glioma Therapeutics Market Report 2026 - Global Outlook – By Type Of Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types), By T...

Paraganglioma Market Report 2026 - Global Outlook – By Type (Sympathetic Paragangliomas, Parasympathetic Paragangliomas, Carotid Paragangliomas, Cervical Paragangliomas, Jugular Paragangliomas, Secretory Paragangliomas, ...

Acoustic Neuroma Market Report 2026 - Global Outlook – By Type (Unilateral Vestibular Schwannomas, Bilateral Vestibular Schwannomas), By Treatment Type (Radiation Therapy, Proton Therapy, Stereotactic Radiosurgery), By D...

Pontine Glioma Drugs Market Report 2026 - Global Outlook – By Type (Diffuse Brain Stem Glioma, Focal Brain Stem Glioma, Recurrent Brain Stem Glioma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Appli...

Brain Tumor Drugs Market Report 2026 - Global Outlook – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other End-Users), By Mechanism of Action (Che...

Frequently Asked Questions

How big is the Glioblastoma Multiforme Market?

The Glioblastoma Multiforme market was valued at $2.7 billion in 2025, increased to $2.92 billion in 2026, and is projected to reach $3.94 billion by 2030. request a sample here

What is the Glioblastoma Multiforme market growth?

The global Glioblastoma Multiforme market is expected to grow at a CAGR of 7.8% from 2026 to 2035 to reach $3.94 billion by 2035. request a sample here

Who are the key players in Glioblastoma Multiforme market?

Some Key Players in the Glioblastoma Multiforme market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Accord Healthcare Inc., Sumitomo Dainippon Pharma Oncology Inc., Karyopharm Therapeutics Inc., ITM Isotope Technologies Munich SE, Azurity Pharmaceuticals Inc., Genenta Science S.p.A., Chimeric Therapeutics Limited, VBI Vaccines Inc. . request a sample here

What is the anticipated growth trend for the Glioblastoma Multiforme market?

Major trend in this market includes: Advancements In CAR T-Cell Therapies For Glioblastoma Multiforme Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Glioblastoma Multiforme market?

North America was the largest region in the glioblastoma multiforme market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Glioblastoma Multiforme Market Report 2026 market?

Major companies operating in the Glioblastoma Multiforme Market Report 2026 market are Major companies operating in the glioblastoma multiforme market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Accord Healthcare Inc., Sumitomo Dainippon Pharma Oncology Inc., Karyopharm Therapeutics Inc., ITM Isotope Technologies Munich SE, Azurity Pharmaceuticals Inc., Genenta Science S.p.A., Chimeric Therapeutics Limited, VBI Vaccines Inc. request a sample here.

Which region has the most growth potential in the Glioblastoma Multiforme Market Report 2026 market?